Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways

Title
Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways
Authors
Keywords
Caffeine, Experimental NASH, Thioacetamide, Fibrosis, MAPK, TGF-β
Journal
Annals of Hepatology
Volume 27, Issue 2, Pages 100671
Publisher
Elsevier BV
Online
2022-01-20
DOI
10.1016/j.aohep.2022.100671

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now